Clinical Trial Update: EXtending the tIme Window of Thrombolysis by ButyphThalide up to 6 Hours After Onset (EXIT-BT) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating the time window for thrombolysis with ButyphThalide in ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke Ischemic

Drugs mentioned

• butyphthalide (butyphthalide)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Stroke, Ischemic | Phase 2 | Status: COMPLETED